Suppr超能文献

疫苗学中的问题:当前挑战与未来方向。

Issues in vaccinology: Present challenges and future directions.

作者信息

Sheerin Dylan, Openshaw Peter Jm, Pollard Andrew J

机构信息

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

the NIHR Oxford Biomedical Research Centre.

出版信息

Eur J Immunol. 2017 Dec;47(12):2017-2025. doi: 10.1002/eji.201746942. Epub 2017 Sep 27.

Abstract

Vaccination is a principal and highly cost-effective means of controlling infectious diseases, providing direct protection against pathogens by conferring long-lasting immunological memory and inducing population-level herd immunity. Despite rapid ongoing progress in vaccinology, there remain many obstacles to the development and deployment of novel or improved vaccines; these include the underlying science of how to induce and sustain appropriate protective immune responses as well as bureaucratic, logistic and socio-political hurdles. The failure to distribute and administer existing vaccines to at-risk communities continues to account for a large proportion of infant mortality worldwide: almost 20 million children do not have access to basic vaccines and several million still die each year as a result. While emerging epidemic or pandemic diseases pose a significant threat to global health and prosperity, there are many infectious diseases which provide a continuous or cyclical burden on healthcare systems which also need to be addressed. Gaps in knowledge of the human immune system stand in the way of developing technologies to overcome individual and pathogenic variation. The challenges in tackling infectious disease and directions that the field of preventive medicine may take to improve the current picture of global health are the focus of this review.

摘要

疫苗接种是控制传染病的主要且极具成本效益的手段,通过赋予持久的免疫记忆和诱导群体水平的 herd 免疫来直接抵御病原体。尽管疫苗学领域目前正在迅速取得进展,但新型或改良疫苗的研发和推广仍存在许多障碍;这些障碍包括如何诱导和维持适当的保护性免疫反应的基础科学,以及官僚、后勤和社会政治方面的障碍。未能将现有疫苗分发和接种到高危社区,仍然是全球婴儿死亡的很大一部分原因:近 2000 万儿童无法获得基本疫苗,每年仍有数百万人因此死亡。虽然新出现的流行病或大流行病对全球健康和繁荣构成重大威胁,但许多传染病也给医疗系统带来持续或周期性负担,也需要加以应对。人类免疫系统知识的空白阻碍了开发克服个体和病原体变异的技术。应对传染病的挑战以及预防医学领域为改善当前全球健康状况可能采取的方向是本综述的重点。

相似文献

1
Issues in vaccinology: Present challenges and future directions.疫苗学中的问题:当前挑战与未来方向。
Eur J Immunol. 2017 Dec;47(12):2017-2025. doi: 10.1002/eji.201746942. Epub 2017 Sep 27.
5
[Novel vaccines. Vaccinations in the near and distant future].[新型疫苗。近期和远期的疫苗接种]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Nov;52(11):1083-90. doi: 10.1007/s00103-009-0953-y.
8
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Oct 10;43(10):1515-1544. doi: 10.3760/cma.j.cn112338-20220825-00734.
9
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840.

引用本文的文献

2
Nanoclays: Promising Materials for Vaccinology.纳米黏土:疫苗学的有前景材料。
Vaccines (Basel). 2022 Sep 17;10(9):1549. doi: 10.3390/vaccines10091549.
3
Moving beyond Titers.超越滴度。
Vaccines (Basel). 2022 Apr 26;10(5):683. doi: 10.3390/vaccines10050683.

本文引用的文献

6
Advances in RSV vaccine research and development - A global agenda.呼吸道合胞病毒疫苗研发进展——一项全球议程。
Vaccine. 2016 Jun 3;34(26):2870-2875. doi: 10.1016/j.vaccine.2016.03.109. Epub 2016 Apr 19.
7
Why don't we have an effective tuberculosis vaccine yet?为什么我们还没有一种有效的结核病疫苗?
Expert Rev Vaccines. 2016 Aug;15(8):1009-13. doi: 10.1586/14760584.2016.1170599. Epub 2016 May 3.
10
The March towards a Vaccine for Congenital CMV: Rationale and Models.迈向先天性巨细胞病毒疫苗的征程:理论依据与模型
PLoS Pathog. 2016 Feb 11;12(2):e1005355. doi: 10.1371/journal.ppat.1005355. eCollection 2016 Feb.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验